AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10424185
Drug: Polyester clothing
RxNorm normalized name: polyester-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyester clothing with low moisture absorption and high air permeability (B)
Trial: 10424185
Drug: Cotton clothing
RxNorm normalized name: Cotton
DrugBank: Cotton (DB10707)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cotton clothing with high moisture absorption and high air permeability (C)
Trial: 7547617
Drug: Oral pancreatic
RxNorm normalized name: pancreatin Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pancreatic enzyme supplements
Trial: 2237719
Drug: Meciadanol, 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meciadanol, 500 mg every six hours through a nasogastric tube
Trial: 2237719
Drug: Sucralfate, 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate, 1,000 mg every six hours through a nasogastric tube
Trial: 2237719
Drug: Antacid (Maalox),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid (Maalox), 15 ml every hour through a nasogastric tube
Trial: 28670677
Drug: Intraurethral lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraurethral lidocaine gel 2% plus intraglandular injection of lidocaine 2% (Group A)
Trial: 28670677
Drug: Intraurethral lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraurethral lidocaine gel 2% alone (Group B)
Trial: 23021709
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy (RT) to the breast/chest wall and regional lymph nodes
Trial: 9175687
Drug: Positive for
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive for anti-beta2GPI antibodies (group II)
Trial: 9175687
Drug: Negative for
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative for both antibodies (group I)
Trial: 1337164
Drug: Interferon (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon (3 x 10(6) units thrice weekly for the first 6 weeks, then twice weekly for a further 8 weeks)
Trial: 3989143
Drug: Epinephrine (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinephrine (high dose)
Trial: 30180054
Drug: Local steroid
RxNorm normalized name: RECTAL,LOCAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local steroid (40 mg of local triamcinolone)
Trial: 30180054
Drug: IV steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV steroid (10 mg of IV dexamethasone)
Trial: 19164187
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 750 microg twice daily
Trial: 16120115
Drug: Mechanical periodontal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical periodontal treatment combined with systemic doxycycline, 100 mg day(‐1) for 14 days
Trial: 16120115
Drug: Neither periodontal
RxNorm normalized name: 2,2',3,3',4,4',5,5',6-nonachlorodiphenyl either
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neither periodontal treatment nor systemic doxycycline
Trial: 12107836
Drug: Gemcitabine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1000 mg/m(2)) + Marimastat
Trial: 12107836
Drug: Gemcitabine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1000 mg/m(2)) + Placebo
Trial: 10402383
Drug: Midazolam 0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.06 mg/kg and Ketamine 0.75 mg/kg
Trial: 10402383
Drug: Fentanyl 0.017
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 0.017 mg/kg, Propofol 2.5 mg/kg and Isoflurane
Trial: 7530597
Drug: Bleomycin (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bleomycin (0.03 unit/ml for 5 hours)
Trial: 2033221
Drug: Continuous nasogastric
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous nasogastric antacid infusion at 0.5 ml/min and i.v. injection of cimetidine 100 mg/h (treatment group)
Trial: 2033221
Drug: Ranitidine 50
RxNorm normalized name: ranitidine 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 50 mg 8 hourly i.v. (control group)
Trial: 7018363
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination tablet containing 5 mg of timolol, 25 mg of hydralazine, 25 mg of hydrochlorothiazide and 37.5 mg of triamterene
Trial: 24051993
Drug: Conventional occupational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional occupational therapy alone
Trial: 23292233
Drug: Selenium (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium (200 mcg twice daily)
Trial: 22145499
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg parecoxib sodium injection (treatment group; n = 133)
Trial: 19307511
Drug: Hormonal therapy
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal therapy duration more than 5 years
Trial: 19307511
Drug: Hormonal therapy
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal therapy duration less than or equal to 1 year
Trial: 19307511
Drug: Hormonal therapy
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal therapy duration more than 1 year and less than or equal to 5 years
Trial: 15637558
Drug: Intranasal amphotericin
RxNorm normalized name: amphotericin
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal amphotericin B (20 mL, 250 mug/mL, twice daily for 6 months)
Trial: 15637558
Drug: Placebo (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (20 mL, twice daily for 6 months)
Trial: 12464951
Drug: Intranasal amphotericin
RxNorm normalized name: amphotericin
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal amphotericin B
Trial: 10076939
Drug: Low-dose glucocorticoid
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose glucocorticoid (prednisone at < 5 mg/day) for at least 12 months
Trial: 10076939
Drug: Nonsteroidal anti‐rheumatic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal anti‐rheumatic drugs (NSAIDs)
Trial: 7720339
Drug: Brain natriuretic
RxNorm normalized name: Brain natriuretic peptide
DrugBank: .gamma.-brain natriuretic peptide (DB19026)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brain natriuretic peptide infusion
Trial: 1817904
Drug: Premedication with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Premedication with a combination of a neuroleptic drug and an opiate or a benzodiazepine
Trial: 7449717
Drug: Zopiclone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopiclone (10 mg)
Trial: 27613814
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of ropivacaine for 24 hours
Trial: 27613814
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline infusion for 24 hours
Trial: 25648969
Drug: Postoperative glenohumeral
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative glenohumeral injection of bupivacaine (20mL) and lidocaine (10mL)
Trial: 25648969
Drug: Postoperative injection
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative injection administered in the subacromial space of bupivacaine (20mL) and lidocaine (10mL)
Trial: 25648969
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of glenohumeral and subacromial injections of bupivacaine (20mL) and lidocaine (10mL)
Trial: 25648969
Drug: Demerol as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Demerol as a postinjection rescue analgesic
Trial: 24055512
Drug: VAC therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAC therapy
Trial: 19755697
Drug: Placebo metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo metformin
Trial: 15300570
Drug: Enteric-coated aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated aspirin 81 mg/day
Trial: 15300570
Drug: Rofecoxib 25
RxNorm normalized name: rofecoxib 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 25 mg combined with aspirin 81 mg/day
Trial: 15300570
Drug: Ibuprofen 800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 800 mg 3 times a day
Trial: 11214056
Drug: Low-dose rhTFPI
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose rhTFPI (0.05 mg/ml)
Trial: 11214056
Drug: High-dose rhTFPI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose rhTFPI (0.15 mg/ml)
Trial: 11214056
Drug: Heparin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (100 U/ml)
Trial: 8082100
Drug: Ondansetron (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (24 mg i.v.) in Study 1
Trial: 8082100
Drug: Granisetron (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (3 mg i.v.) in Study 1
Trial: 8082100
Drug: Ondansetron (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (8 mg orally twice a day) for delayed emesis in Study 1
Trial: 8082100
Drug: Granisetron (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (3 mg i.v.) for delayed emesis in Study 1
Trial: 8082100
Drug: Ondansetron (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (16 mg i.v.) in Study 2
Trial: 8082100
Drug: Granisetron (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (3 mg i.v.) in Study 2
Trial: 2644877
Drug: Nifedipine 20
RxNorm normalized name: nifedipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 20 mg daily
Trial: 6486124
Drug: Nifedipine 40
RxNorm normalized name: nifedipine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 40 mg daily
Trial: 2644877
Drug: Nifedipine (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (both doses)
Trial: 1103213
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (30 to 240 mg of elemental iron as ferrous fumarate)
Trial: 1103213
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (120 mg of iron without B12 or folate)
Trial: 1103213
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (120 mg or more)
Trial: 18095948
Drug: Program 1
RxNorm normalized name: 0.4 ML Program 100 MG/ML Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Program 1 (self-adjusted insulin dose)
Trial: 18095948
Drug: Program 2
RxNorm normalized name: Program 205 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Program 2 (investigator-reminded insulin dose)
Trial: 10230181
Drug: Stimulant medications
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulant medications
Trial: 15723384
Drug: Extended-release delivery
RxNorm normalized name: tramadol
DrugBank: Tramadol (DB00193)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Extended-release delivery systems
Trial: 15723384
Drug: Second-line medications
RxNorm normalized name: Gallus gallus gizzard lining preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-line medications
Trial: 15723384
Drug: Medication adjustment
RxNorm normalized name: DEPEND ADJUSTABLE,MAXIMUM SM/MED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication adjustment
Trial: 12230618
Drug: 3-month course
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-month course of a gonadotrophin-releasing hormone analogue before surgery
Trial: 7808649
Drug: Ketorolac 30
RxNorm normalized name: ketorolac 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 30 mg suppositories
Trial: 7808649
Drug: Ketorolac 10
RxNorm normalized name: ketorolac 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 10 mg suppositories
Trial: 2574192
Drug: Trihexyphenidyl hydrochloride
RxNorm normalized name: Trihexyphenidyl Hydrochloride
DrugBank: Trihexyphenidyl (DB00376)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trihexyphenidyl hydrochloride (HCl), 4 mg dose
Trial: 4601508
Drug: Prophylactic dose
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic dose of 0.25 g
Trial: 4601508
Drug: Prophylactic dose
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic dose of 1 g
Trial: 4601508
Drug: Prophylactic dose
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic dose of 2 g
Trial: 4601508
Drug: Therapeutic dose
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic dose of 4 g on the first day of illness
Trial: 4601508
Drug: Therapeutic dose
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic dose of 8 g on the first day of illness
Trial: 4601508
Drug: Combination regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination regimen (1 g daily and 4 g on the first day of illness)
Trial: 30572875
Drug: Biological disease-modifying-antirheumatic-drug
RxNorm normalized name: Quinolines, antirheumatic drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological disease-modifying-antirheumatic-drug (DMARD) strategy
Trial: 26317483
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A palmitate eye gel 0.1%
Trial: 26317483
Drug: Carbomer eye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbomer eye gel 0.2%
Trial: 26317483
Drug: No additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No additional application of vitamin A palmitate or carbomer gel
Trial: 25270629
Drug: Cutamesine 1
RxNorm normalized name: Cutamesine
DrugBank: Cutamesine (DB06618)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cutamesine 1 mg/d
Trial: 25270629
Drug: Cutamesine 3
RxNorm normalized name: Cutamesine
DrugBank: Cutamesine (DB06618)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cutamesine 3 mg/d
Trial: 21038648
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine intestine adjusting therapy (IAT) with electro-acupuncturing and retention enema
Trial: 21038648
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine intestine adjusting therapy (IAT)
Trial: 21038648
Drug: Conventional drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional drug therapy and bi-level positive airway pressure ventilation
Trial: 11581481
Drug: 30 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/kg acetaminophen loading dose
Trial: 11581481
Drug: 15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg acetaminophen maintenance dose
Trial: 7978097
Drug: Nicotine dependence
RxNorm normalized name: Drugs used in nicotine dependence
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine dependence treatment (consultation, 10 intervention sessions, structured relapse prevention program)
Trial: 7978097
Drug: Nicotine dependence
RxNorm normalized name: Drugs used in nicotine dependence
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine dependence treatment
Trial: 31671276
Drug: EPA+DHA supplementation
RxNorm normalized name: eicosapentaenoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA+DHA supplementation (600 mg EPA and 260 mg DHA per day for 8 weeks)
Trial: 31671276
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group (matching capsules for the same duration of time)
Trial: 27441600
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (6 g/day; 5:1 EPA:DHA)
Trial: 27441600
Drug: Placebo (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (6 g/day corn/soy oil)
Trial: 25871304
Drug: Best medical/surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best medical/surgical management plus daily supplementation of vitamin B6, vitamin B12, and folic acid
Trial: 23698211
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injection (B)
Trial: 23698211
Drug: Placebo (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline solution) (S)
Trial: 21854650
Drug: Krill oil
RxNorm normalized name: Krill oil
DrugBank: Krill oil (DB16615)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Krill oil (1680 mg EPA+DHA)
Trial: 21854650
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil rTAG (1680 mg EPA+DHA)
Trial: 21854650
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil EE (1680 mg EPA+DHA)
Trial: 17845684
Drug: Serotonin agonists
RxNorm normalized name: serotonin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotonin agonists (cisapride and mosapride)
Trial: 17845684
Drug: Control agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control agents (dopamine antagonists: metoclopramide and domperidone; opiate agonist: trimebutine)
Trial: 7836550
Drug: Lovastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin (40 mg)
Trial: 24481828
Drug: Ultrasound-guided leukocyte-rich
RxNorm normalized name: interferon alfa-3n,human leukocyte derived
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided leukocyte-rich PRP injection with standardized eccentric exercises
Trial: 1395888
Drug: Control group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group: no antibiotics given
Trial: 31505519
Drug: Escitalopram (SRI)
DrugBank: Escitalopram (DB01175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Escitalopram (SRI) treatment
Trial: 28933625
Drug: IIV4 (quadrivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IIV4 (quadrivalent split‐virion inactivated influenza vaccine)
Trial: 28933625
Drug: IIV3 (licensed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IIV3 (licensed split‐virion trivalent inactivated influenza vaccine)
Trial: 9862513
Drug: 120FEC with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120FEC with early primary G-CSF (days 4 to 13)
Trial: 9862513
Drug: 60FEC without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 60FEC without G-CSF
Trial: 8543644
Drug: Aspirin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (50 ml solution, concentration 3 mg/ml)
Trial: 2093112
Drug: Intravenous immunoglobulins
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulins at doses of 1 g/Kg/day
Trial: 2093112
Drug: Randomized therapy
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Randomized therapy (Control)
Trial: 272413
Drug: Irrigation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irrigation with Lugol's solution
Trial: 29256465
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml of 0.9% saline solution
Trial: 29256465
Drug: 250 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 ml of 0.9% saline solution
Trial: 23148500
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (Amlodipine and Valsartan)
Trial: 16984797
Drug: Antenatal betamethasone
RxNorm normalized name: Betamethasone
DrugBank: Betamethasone phosphate (DB14669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antenatal betamethasone treatment (single course)
Trial: 14697925
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg twice daily
Trial: 11099808
Drug: Negative patterning
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative patterning (NP) group with letter stimuli (C, N, M, J) reinforced by shock when alone but not in compound.
Trial: 11099808
Drug: Negative patterning
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative patterning (NP) group with one pair of letters reinforced as elements but not in compound.